Symptomatic intracranial stenosis

Best medical treatment vs. intracranial stenting

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose of review The high risk of stroke and death in patients with symptomatic intracranial stenosis despite medical therapy has spurred interest in endovascular treatment approaches. Recent findings Three stents have been designed for the treatment of intracranial stenosis, and two, the Wingspan and Neurolink Stent Systems, have been evaluated in single-arm trials. The trials and two prospective registries evaluating the Wingspan Stent System suggest that stenting is most likely to be beneficial in patients with the highest risk of stroke on medical therapy, namely those with 70-99% stenosis. Summary Randomized treatment trials comparing stenting with medical therapy in symptomatic intracranial stenosis need to target the patients at highest risk of recurrent vascular events on medical therapy. Such trials are in progress. Ongoing trials in Asia are also assessing medical therapies, including cilostazol, in patients with intracranial stenosis.

Original languageEnglish (US)
Pages (from-to)69-74
Number of pages6
JournalCurrent Opinion in Neurology
Volume22
Issue number1
DOIs
StatePublished - Feb 2009

Fingerprint

Pathologic Constriction
Stents
Therapeutics
Stroke
Blood Vessels
Registries

Keywords

  • Angioplasty
  • Intracranial stenosis
  • Stent
  • Stroke
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Symptomatic intracranial stenosis : Best medical treatment vs. intracranial stenting. / Lutsep, Helmi.

In: Current Opinion in Neurology, Vol. 22, No. 1, 02.2009, p. 69-74.

Research output: Contribution to journalArticle

@article{affe29b7ec9d46c6aae0978beeb47d4d,
title = "Symptomatic intracranial stenosis: Best medical treatment vs. intracranial stenting",
abstract = "Purpose of review The high risk of stroke and death in patients with symptomatic intracranial stenosis despite medical therapy has spurred interest in endovascular treatment approaches. Recent findings Three stents have been designed for the treatment of intracranial stenosis, and two, the Wingspan and Neurolink Stent Systems, have been evaluated in single-arm trials. The trials and two prospective registries evaluating the Wingspan Stent System suggest that stenting is most likely to be beneficial in patients with the highest risk of stroke on medical therapy, namely those with 70-99{\%} stenosis. Summary Randomized treatment trials comparing stenting with medical therapy in symptomatic intracranial stenosis need to target the patients at highest risk of recurrent vascular events on medical therapy. Such trials are in progress. Ongoing trials in Asia are also assessing medical therapies, including cilostazol, in patients with intracranial stenosis.",
keywords = "Angioplasty, Intracranial stenosis, Stent, Stroke, Treatment",
author = "Helmi Lutsep",
year = "2009",
month = "2",
doi = "10.1097/WCO.0b013e32831504e4",
language = "English (US)",
volume = "22",
pages = "69--74",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Symptomatic intracranial stenosis

T2 - Best medical treatment vs. intracranial stenting

AU - Lutsep, Helmi

PY - 2009/2

Y1 - 2009/2

N2 - Purpose of review The high risk of stroke and death in patients with symptomatic intracranial stenosis despite medical therapy has spurred interest in endovascular treatment approaches. Recent findings Three stents have been designed for the treatment of intracranial stenosis, and two, the Wingspan and Neurolink Stent Systems, have been evaluated in single-arm trials. The trials and two prospective registries evaluating the Wingspan Stent System suggest that stenting is most likely to be beneficial in patients with the highest risk of stroke on medical therapy, namely those with 70-99% stenosis. Summary Randomized treatment trials comparing stenting with medical therapy in symptomatic intracranial stenosis need to target the patients at highest risk of recurrent vascular events on medical therapy. Such trials are in progress. Ongoing trials in Asia are also assessing medical therapies, including cilostazol, in patients with intracranial stenosis.

AB - Purpose of review The high risk of stroke and death in patients with symptomatic intracranial stenosis despite medical therapy has spurred interest in endovascular treatment approaches. Recent findings Three stents have been designed for the treatment of intracranial stenosis, and two, the Wingspan and Neurolink Stent Systems, have been evaluated in single-arm trials. The trials and two prospective registries evaluating the Wingspan Stent System suggest that stenting is most likely to be beneficial in patients with the highest risk of stroke on medical therapy, namely those with 70-99% stenosis. Summary Randomized treatment trials comparing stenting with medical therapy in symptomatic intracranial stenosis need to target the patients at highest risk of recurrent vascular events on medical therapy. Such trials are in progress. Ongoing trials in Asia are also assessing medical therapies, including cilostazol, in patients with intracranial stenosis.

KW - Angioplasty

KW - Intracranial stenosis

KW - Stent

KW - Stroke

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=60449084475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60449084475&partnerID=8YFLogxK

U2 - 10.1097/WCO.0b013e32831504e4

DO - 10.1097/WCO.0b013e32831504e4

M3 - Article

VL - 22

SP - 69

EP - 74

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 1

ER -